Peptide Epithalon Extends Human Cell Lifespan by Restoring Telomeres

Cellular senescence, a state where cells permanently stop dividing, is a fundamental process implicated in aging and various age-related diseases like cardiovascular disease and neurodegeneration. This phenomenon is often linked to the Hayflick limit, which describes the finite number of times normal human somatic cells can divide before reaching replicative exhaustion, largely due to the progressive shortening of telomeres (protective caps at the ends of chromosomes). While previous research from this group demonstrated that the tetrapeptide Epithalon (Ala-Glu-Asp-Gly) could induce the expression and enzymatic activity of telomerase (the enzyme that maintains telomere length) and elongate telomeres in normal human diploid cells, the direct impact on extending cellular proliferative potential remained less explored. This study aimed to specifically investigate Epithalon's capacity to overcome the Hayflick limit and significantly prolong the replicative lifespan of human somatic cells.

The control group of human fetal fibroblasts consistently ceased division at passage 34, confirming their inherent Hayflick limit. In stark contrast, the cells treated with Epithalon exhibited a remarkable restoration of telomere length; the peptide induced elongation of telomeres to a size comparable to their robust length observed during early passages (e.g., passage 10). This telomere restoration was directly correlated with a significant extension of their proliferative capacity. > Epithalon-treated cells underwent an additional 10 divisions, reaching a total of 44 passages, and critically, continued to divide beyond this point, effectively demonstrating their ability to overcome the Hayflick limit. This represents a substantial 29.4% increase in total divisions compared to the untreated control cells' 34 passages. The study thus confirmed that Epithalon not only elongates telomeres but directly translates this into an extended cellular lifespan.